0.8  0.008 (1.01%)		04-15 16:00
Open: 0.7875 High: 0.8078 Volume: 303,564		Pre. Close: 0.792 Low: 0.78 Market Cap: 31(M)

Short term
Mid term
Targets	6-month :	0.94	1-year :	1.1
Resists	First :	0.8	Second :	0.94
Pivot price	0.7
Supports	First :	0.68	Second :	0.6
MAs	MA(5) :	0.74	MA(20) :	0.7
	MA(100) :	0.84	MA(250) :	1.54
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	95.5	D(3) :	85.3
RSI	RSI(14): 61.6
52-week	High :	4.98	Low :	0.6

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ MYO ] has closed Bollinger Bands are 22.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.81 - 0.81	0.81 - 0.81
Low:	0.77 - 0.78	0.78 - 0.78
Close:	0.79 - 0.8	0.8 - 0.8

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Tue, 14 Apr 2026
Myomo (MYO) CEO trades three months salary for 16,666 RSUs - Stock Titan

Tue, 14 Apr 2026
Myomo (NYSE: MYO) CFO swaps salary for RSUs and uses shares for tax - Stock Titan

Tue, 14 Apr 2026
Myomo (MYO) CEO swaps salary for 19,395 RSU equity award - Stock Titan

Mon, 13 Apr 2026
[144] MYOMO, INC. SEC Filing - Stock Titan

Sat, 11 Apr 2026
Myomo, Inc. (MYO) reports Q4 loss, tops revenue estimates - MSN

Tue, 10 Mar 2026
Craig-Hallum cuts Myomo stock price target to $1.10 on guidance miss - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.